The Covid-19 pandemic put thousands of clinical trials on hold, but it also showed pharma companies, regulators and clinicians that decentralized clinical trials are a less expensive, more convenient and equally as effective method for generating clinical research. Dessiree Paoli, Sr. Solutions Marketing Manager for Interlace Health, discusses how decentralized clinical trials are improving engagement with study participants, improving data capture and shortening time to market for crucial drugs.
Educational
Interesting
Funny
Agree
Love
Wow
Are you the creator of this podcast?
and pick the featured episodes for your show.
Connect with listeners
Podcasters use the RadioPublic listener relationship platform to build lasting connections with fans
Yes, let's begin connectingFind new listeners
Understand your audience
Engage your fanbase
Make money